Validation Data Gallery
Product Information
| Concentration | 0.2 mg/mL |
| Applications | ELISA, WB, Dot blot |
| Host Species | Goat |
| Species Reactivity | Rabbit |
| Physical State | Liquid |
| Suggested Dilution Range | For western blotting with ECL substrates: ECL Detection Kit (PK10001): 1:2,000-1:10,000 Sensitive ECL Detection Kit (PK10002):1:5,000-1:20,000 Ultrasensitive ECL Detection Kit (PK10003): 1:10,000-40,000 For ELISA and Western blotting with chromogenic substrates: 1:1,000-1:20,000 |
| Purity | The antibody was purified from antisera by immunoaffinity chromatography using antigens coupled to agarose beads. |
| Storage Buffer | 0.01 M Sodium phosphate, 0.25 M NaCl, 50% glycerol, 3 mg/ml BSA, pH 7.6. |
| Storage Instructions | Store at -20°C. Stable for one year after shipment. |
| Stabilizer | 3 mg/ml BSA |
| Clonality | Polyclonal |
| RRID | AB_2722564 |
| Note | This product is for research use only,not for diagnostic or therapeutic use. |
Publications
| Title |
|---|
Signal Transduct Target Ther Fructose directly remodels the translocase of the outer membrane to impair oxidative phosphorylation in podocytes |
Signal Transduct Target Ther Krüppel-like factor 4 downregulation during esophageal cancer formation facilitates immune evasion and impairs immunotherapy |
Signal Transduct Target Ther Fructose 1-phosphate inhibits mannose phosphate isomerase to suppress hepatocellular carcinogenesis |
Signal Transduct Target Ther Lysophosphatidylethanolamine 18:1 drives clear cell renal cell carcinoma by stabilizing SIRT6 to reprogram lipid metabolism. |
Signal Transduct Target Ther Social memory maintenance relies on social interaction-induced proteolytic products of neuroligin 1. |
Signal Transduct Target Ther Activation of Nerve Growth Factor signaling limits the response to lenvatinib in hepatocellular carcinoma |

